Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Sichuan Kelan Pharmaceutical Research Institute Co., Ltd.

Sichuan Kelun Pharmaceutical Research Institute Co. Ltd.

Tianming Wang

Jingyi Wang

Lichun Wang

Qiang Tian

Jiaqiang Cai

Chengxi Yang

Wei Liu

Baolei Zhang

Shuai Song

Mingliang Zhao

Yufeng Liang

Xing Chen

Shidong Yi

Zheng Gong

Hao Hu

Weibiao Han

Youqiang Li

Disclosed are a solid form of (E)-3-((R)-4-(((R)-6-(2-chloro-4-fluorophenyl)-5-(methoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)acrylic acid, a preparation method therefor, a pharmaceutical composition comprising same, and the use thereof in the preparation of drugs for preventing or treating viral diseases.

Solid form of dihydropyrimidine compound and preparation method therefor and use thereof

The present invention relates to compounds represented by formula (I) and formula (II) and a chiral synthesis and chiral isolation method therefor, further relating to a salt and crystal form of the compound represented by formula (I), a preparation method therefor, a pharmaceutical composition comprising the same, and use thereof in the preparation of a medicament used for the treatment of a viral infectious disease such as hepatitis B. 

Phosphonamide ester compound, salt thereof, related crystal form thereof, preparation method therefor and use thereof

The invention relates to a crystal form of 4-phenylthiazole derivative, a pharmaceutical composition comprising the same, a preparation method, and a use of the crystal form for the manufacture of a medicament for treating thrombocytopenia. 

Crystal form of 4-phenylthiazole derivative and preparation method thereof

Growing community of inventors

Chengdu, China

Tianming Wang